PTA-News: Biofrontera AG: Biofrontera improves the brand protection of Ameluz®-PDT in the US and strengthens internal quality assurance structures
Biofrontera , an international biopharmaceutical company, announces that the U.S. Food and Drug Administration has added the patent of novel RhodoLED® XL lamp to the FDA Orange Book and further... | March 14, 2022